Botana, M. (., Escalada, J. (., Merchante, Á. (., Reyes, R. (., & Rozas, P. (. (2022). Prevention of cardiorenal complications with sodium-glucose cotransporter type 2 inhibitors: A narrative review.
Citação norma ChicagoBotana, M. (Manuel)|||/items/d7e00c95-bca2-49d1-bfe8-3b27d6aaf75f, J. (Javier)|||/items/49a6b2d2-0f66-4005-b584-099f1728e80b Escalada, Á. (Ángel)|||/items/1a928ffa-c758-4ad0-bd78-478d5b473a9f Merchante, R. (Rebeca)|||/items/f7c7f3a8-6974-4b71-9e1d-cee7a719a4f9 Reyes, y P. (Pedro)|||/items/3bea6418-a2ca-44fd-8d91-71ebe016d2a4 Rozas. Prevention of Cardiorenal Complications With Sodium-glucose Cotransporter Type 2 Inhibitors: A Narrative Review. 2022.
Citação norma MLABotana, M. (Manuel)|||/items/d7e00c95-bca2-49d1-bfe8-3b27d6aaf75f, et al. Prevention of Cardiorenal Complications With Sodium-glucose Cotransporter Type 2 Inhibitors: A Narrative Review. 2022.